Follow
Kenneth S Chen
Kenneth S Chen
Pediatrics, UT Southwestern
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
MA Cooper, TA Fehniger, SC Turner, KS Chen, BA Ghaheri, T Ghayur, ...
Blood, The Journal of the American Society of Hematology 97 (10), 3146-3151, 2001
18712001
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
D Rakheja, KS Chen, Y Liu, AA Shukla, V Schmid, TC Chang, S Khokhar, ...
Nature communications 5 (1), 4802, 2014
2502014
p53 genes function to restrain mobile elements
A Wylie, AE Jones, A D'Brot, WJ Lu, P Kurtz, JV Moran, D Rakheja, ...
Genes & development 30 (1), 64-77, 2016
1982016
DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors
JF Amatruda, JA Ross, B Christensen, NJ Fustino, KS Chen, AJ Hooten, ...
BMC cancer 13, 1-13, 2013
432013
A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse
K Singleton, N Parvaze, KR Dama, KS Chen, P Jennings, B Purtic, ...
The Journal of Immunology 177 (7), 4402-4413, 2006
432006
Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1
KS Chen, EK Stroup, A Budhipramono, D Rakheja, D Nichols-Vinueza, ...
Genes & development 32 (15-16), 996-1007, 2018
402018
Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides
KS Chen, A Bach, A Shoup, NJ Winick
Pediatric blood & cancer 60 (11), 1772-1777, 2013
322013
EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors
KS Chen, NJ Fustino, AA Shukla, EK Stroup, A Budhipramono, C Ateek, ...
Molecular cancer therapeutics 17 (5), 1079-1089, 2018
182018
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
KS Chen, WS Kwon, J Kim, SJ Heo, HS Kim, HK Kim, SH Kim, WS Lee, ...
Molecular Case Studies 2 (5), a000992, 2016
152016
Distinct DICER1 hotspot mutations identify bilateral tumors as separate events
KS Chen, SH Stuart, EK Stroup, AS Shukla, J Wang, V Rajaram, ...
JCO precision oncology 2, 2018
132018
Integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis
KE Medvedev, AV Savelyeva, KS Chen, A Bagrodia, L Jia, NV Grishin
Cancer informatics 21, 11769351221132634, 2022
92022
External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer
HJ Lee, A Lee, XY Yang, YM Law, HH Huang, WKO Lau, LS Lee, HSS Ho, ...
Urologic Oncology: Seminars and Original Investigations 39 (11), 783. e1-783 …, 2021
72021
WT‐CLS1 is a rhabdoid tumor cell line and can be inhibited by miR‐16
EK Stroup, Y Yeu, A Budhipramono, TH Hwang, D Rakheja, ...
Cancer reports 2 (3), e1110, 2019
72019
Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively‐maintained database
K Chen, A Lee, HH Huang, KJ Tay, A Sim, LS Lee, CWS Cheng, LG Ng, ...
International Journal of Urology 26 (4), 465-474, 2019
62019
A big catch for germ cell tumour research
KS Chen, JF Amatruda
PLoS genetics 9 (4), e1003481, 2013
62013
Specifications of the ACMG/AMP Variant Classification Guidelines for Germline DICER1 Variant Curation
JN Hatton, MN Frone, HC Cox, SB Crowley, S Hiraki, NN Yokoyama, ...
Human mutation 2023, 2023
42023
Extrarenal anaplastic Wilms tumor: a case report with genomic analysis and tumor models
KR Willis, AA Sathe, C Xing, P Koduru, M Artunduaga, EB Butler, JY Park, ...
Journal of pediatric hematology/oncology 44 (4), 147-154, 2022
42022
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
L Xu, JL Pierce, A Sanchez, KS Chen, AA Shukla, NJ Fustino, SH Stuart, ...
Nature communications 14 (1), 2636, 2023
32023
Wilms tumor mutational subclasses converge to drive CCND2 overexpression
L Xu, K Desai, J Kim, Q Zhou, L Guo, X Xiao, Y Zhang, L Zhou, A Yuksel, ...
medRxiv, 2023
22023
Invited reply to amikacin ototoxicity in children with cancer: the problem is the administration schedule.
K Chen, A Bach, A Shoup, N Winick
Pediatric blood & cancer 61 (2), 191-191, 2013
22013
The system can't perform the operation now. Try again later.
Articles 1–20